| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.96.10.3710 |
| P698 | PubMed publication ID | 9396475 |
| P50 | author | Maurits Allessie | Q20810408 |
| P2093 | author name string | Power J | |
| Kirchhof CJ | |||
| Dorland R | |||
| Wijffels MC | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Atrial Fibrillation | Q815819 |
| P304 | page(s) | 3710-3720 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation | |
| P478 | volume | 96 |
| Q37989837 | 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design |
| Q55263071 | 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design |
| Q45059153 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation |
| Q46658026 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation |
| Q28552038 | A Mathematical Model of Neonatal Rat Atrial Monolayers with Constitutively Active Acetylcholine-Mediated K+ Current |
| Q37089729 | A genetic framework for improving arrhythmia therapy. |
| Q37098363 | Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF). |
| Q51940093 | Action potential morphology heterogeneity in the atrium and its effect on atrial reentry: a two-dimensional and quasi-three-dimensional study. |
| Q28362668 | Acute pressure overload cardiac arrhythmias are dependent on the presence of myocardial tissue catecholamines |
| Q36016921 | Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation |
| Q37398677 | Atrial fibrillation begets atrial fibrillation: autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing |
| Q34959876 | Atrial fibrillation electrical remodelling via ablation of the epicardial neural networks and suprathreshold stimulation of vagosympathetic nerve |
| Q34091039 | Atrial fibrillation: the most common arrhythmia |
| Q38152975 | Atrial fibrillation: to map or not to map? |
| Q75252437 | Atrial refractoriness and action potential duration after sudden reversal of atrioventricular sequence |
| Q79263391 | Atrial vulnerability: a new protocol by bigeminy pacing |
| Q76395946 | Basic mechanisms of atrial fibrillation |
| Q37808764 | Biomarkers in Atrial Fibrillation, Ventricular Arrhythmias, and Sudden Cardiac Death |
| Q34598498 | Burden and timing of premature atrial contractions after electrical cardioversion of persistent atrial fibrillation do not predict its recurrence. |
| Q28601309 | Cardiac Mechano-Gated Ion Channels and Arrhythmias. |
| Q33792556 | Cardiac adrenergic control and atrial fibrillation |
| Q38042920 | Cardiac electrophysiology in mice: a matter of size |
| Q38701602 | Central Sympathetic Inhibition: a Neglected Approach for Treatment of Cardiac Arrhythmias? |
| Q33924902 | Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy |
| Q38326291 | Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atri |
| Q44487854 | Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation |
| Q33984032 | Effects of low-intensity autonomic nerve stimulation on atrial electrophysiology |
| Q28362672 | Effects of pretreatment with verapamil on early recurrences after electrical cardioversion of persistent atrial fibrillation: a randomised study |
| Q46810409 | Effects of verapamil and procainamide on acute atrial electrical remodeling induced by short-term rapid atrial pacing in humans |
| Q48010227 | Efficacy of ganglionated plexi ablation in addition to pulmonary vein isolation for paroxysmal versus persistent atrial fibrillation: a meta-analysis of randomized controlled clinical trials. |
| Q37206685 | Electrical PR Interval Variation Predicts New Occurrence of Atrial Fibrillation in Patients With Frequent Premature Atrial Contractions |
| Q44646067 | Electrophysiologic remodeling and drug treatment of atrial fibrillation |
| Q34172170 | Evaluation and management of atrial fibrillation |
| Q79151854 | Evidence of mechanoelectric feedback in the atria of patients with atrioventricular nodal reentrant tachycardia |
| Q35198963 | Evolving concepts in the treatment of atrial fibrillation |
| Q34126368 | Experimental models of atrial fibrillation/flutter |
| Q43012937 | Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies |
| Q34561350 | Fibroblast electrical remodeling in heart failure and potential effects on atrial fibrillation |
| Q36455977 | Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia |
| Q37384615 | First And Second-Generation Cryoballoon Ablation Efficacy Restoring And Maintaining Sinus Rhythm In Patients Electrically Selected And Treated For Long-Standing Persistent Atrial Fibrillation After Acute Complete Electrical Disconnection Of Pulmonar |
| Q45077753 | Inositol-1,4,5-trisphosphate induced Ca2+ release and excitation-contraction coupling in atrial myocytes from normal and failing hearts |
| Q44856422 | Intravenous enalapril does not prevent tachycardia-induced acute atrial electrical remodeling |
| Q53829302 | Introduction to this special issue on neurourology. Urinary incontinence. |
| Q37466121 | Left versus right atrial difference in dominant frequency, K(+) channel transcripts, and fibrosis in patients developing atrial fibrillation after cardiac surgery |
| Q34778156 | Maintaining stability of sinus rhythm in atrial fibrillation: antiarrhythmic drugs versus ablation |
| Q73156971 | Marked reduction in atrial defibrillation thresholds with repeated internal cardioversion |
| Q37844891 | Mechanisms of termination and prevention of atrial fibrillation by drug therapy |
| Q35121835 | Mechano-electric feedback and atrial fibrillation. |
| Q35121844 | Mechano-electrical feedback underlying arrhythmias: the atrial fibrillation case |
| Q80424523 | Minimally invasive pulmonary vein isolation and partial autonomic denervation for surgical treatment of atrial fibrillation |
| Q43151343 | NFAT-dependent excitation-transcription coupling in heart |
| Q37106294 | New concepts in understanding and modulating atrial repolarisation in patients with atrial fibrillation |
| Q34503407 | New ideas about atrial fibrillation 50 years on. |
| Q34289414 | New insights into the mechanisms and management of atrial fibrillation |
| Q30542175 | Non-invasive characterisation of coronary lesion morphology by multi-slice computed tomography: a promising new technology for risk stratification of patients with coronary artery disease |
| Q33789892 | Novel catheter technology for ablative cure of atrial fibrillation |
| Q27025392 | Patient-specific flexible and stretchable devices for cardiac diagnostics and therapy |
| Q73321664 | Postcardioversion atrial electrophysiologic changes induced by oral verapamil in patients with persistent atrial fibrillation |
| Q77456453 | Predictors of unsuccessful electrical cardioversion in atrial fibrillation |
| Q73199903 | Recovery of the right atrial effective refractory period after cardioversion of chronic atrial fibrillation |
| Q42850841 | Relationship Between the Long-Term Preventive Effect of Combined Treatment With Antiarrhythmic Drugs Plus Angiotensin-Converting Enzyme Inhibitors and Circadian Variation in the Onset of Paroxysmal Atrial Fibrillation |
| Q35315302 | Remodeling of atrial ATP-sensitive K⁺ channels in a model of salt-induced elevated blood pressure |
| Q37881037 | Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation |
| Q30356863 | Role of Echocardiography in Atrial Fibrillation Ablation |
| Q35582341 | Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil. |
| Q37496071 | Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation |
| Q57021472 | Targeting amino acids metabolic profile to identify novel metabolic characteristics in atrial fibrillation |
| Q33585540 | The Autonomic Nervous System and Atrial Fibrillation:The Roles of Pulmonary Vein Isolation and Ganglionated Plexi Ablation |
| Q39274977 | The Electrophysiologic Effects of Acute Mitral Regurgitation in a Canine Model. |
| Q38790370 | The Role of the Atrial Neural Network In Atrial Fibrillation: The Metastatic Progression Hypothesis |
| Q84371668 | The atrial neural network as a substrate for atrial fibrillation |
| Q39119910 | The burden of proof: The current state of atrial fibrillation prevention and treatment trials |
| Q78861339 | The influence of spontaneous termination of atrial fibrillation on P wave-triggered signal-averaged electrocardiogram |
| Q36065273 | The intrinsic autonomic nervous system in atrial fibrillation: a review |
| Q35121840 | The role of atrial dilatation in the domestication of atrial fibrillation |
| Q38572396 | The role of the autonomic ganglia in atrial fibrillation |
| Q33861831 | The tachycardia-induced dog model of atrial fibrillation. clinical relevance and comparison with other models |
| Q43037991 | Transient appearance of antegrade conduction via an AV accessory pathway caused by atrial fibrillation in a patient with intermittent Wolff-Parkinson-White syndrome |
| Q44658381 | Verapamil Suppresses the Inhomogeneity of Electrical Remodeling in a Canine Long‐Term Rapid Atrial Stimulation Model |
| Q73650865 | [Anatomic atrial remodeling after mitral valve surgery in permanent atrial fibrillation] |
| Q83198021 | [Animal models of cardiovascular disease] |
Search more.